Fuula Jalqabaa › Tajaajiltoota › Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp.: Baajannaa H-1B fi deggera
Kiniksa Pharmaceuticals Corp. iyyannoo hojii haala 7 H-1B fi viizaa walitti dhufeenya qaban bara maallaqaa 2023–2026 irratti galche; mirkaneessame: 7. Baajannaa giddugaleessaa dhiyaate: $140,000.
Kiniksa Pharmaceuticals Corp. viizaa H-1B deggeraa?
Kiniksa Pharmaceuticals Corp. bara maallaqaa 2023–2026 irratti iyyannoo hojii haala 7 galche, kan haaraan 09-Cam-2025 irratti dhiyaate. LCA tarsiimoo jalqabaa iyyannoo H-1B ti, hojii kennaan hojjettoota H-1B deggereera yookaan deggeruuf qophii ta'eera; hojii adda addaaf deggera hin mirkaneessu. Galmee hojii hojii kennaa isaa ilaali.
Baajannaa maqaa hojii irratti
| Mata-duree hojii | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| Director, Biostatistics | 1 | $137,966 |
| Associate Scientist, Analytical Sciences & Quality Testing | 1 | $98,000 |
| Director, Medical Affairs – Real-World Evidence & Epidemiolo | 1 | $220,000 |
| Manager, Quality Control | 1 | $140,000 |
| Scientist, Analytical Science & Quality Testing | 1 | $109,802 |
| Senior Director, Global Medical Safety | 1 | $290,000 |
| Associate Director, Clinical Quality Assurance | 1 | $189,930 |
Iyyannoo bara maallaqaa irratti
| Bara maallaqaa | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| FY2023 | 3 | $137,966 |
| FY2024 | 2 | $124,901 |
| FY2025 | 2 | $239,965 |
Sadarkaa baajannaa olaanaa
Dhaabbanni Hojii sadarkaa baajannaa olaanaa afur hojii tokkoo tokkoo fi bakkaaf, Sadarkaa I (jalqabaa) hanga Sadarkaa IV (guddisaa) jiru, kaa'a. Hojii kennaan sadarkaa hojii sanaaf madaalu filata.
Hojiiwwan eessa jiru
Hojiiwwan
- Statisticians1
- Biochemists and Biophysicists1
- Epidemiologists1
- Industrial Engineers1
- Chemists1
- Regulatory Affairs Managers1
- Regulatory Affairs Specialists1
Iyyannoo haaraa
| Mata-duree hojii | Baasii bu'uuraa | Bakka | Dhiyaate | Guyyaa jalqabaa | Haala |
|---|---|---|---|---|---|
| Associate Director, Clinical Quality Assurance | $189,930 Sadarkaa IV | Lexington, MA | 09-Cam-2025 | 01-Onk-2025 | Mirkaneffame |
| Senior Director, Global Medical Safety | $290,000 Sadarkaa IV | Lexington, MA | 13-Bit-2025 | 07-Elb-2025 | Mirkaneffame |
| Scientist, Analytical Science & Quality Testing | $109,802 | Lexington, MA | 29-Gur-2024 | 28-Hag-2024 | Mirkaneffame |
| Manager, Quality Control | $140,000 Sadarkaa IV | Lexington, MA | 07-Sad-2023 | 13-Sad-2023 | Mirkaneffame |
| Director, Medical Affairs – Real-World Evidence & Epidemiolo | $220,000 Sadarkaa IV | Lexington, MA | 30-Wax-2023 | 24-Ado-2023 | Mirkaneffame |
| Associate Scientist, Analytical Sciences & Quality Testing | $98,000 Sadarkaa I | Lexington, MA | 11-Elb-2023 | 01-Onk-2023 | Mirkaneffame |
| Director, Biostatistics | $137,966–$230,000 Sadarkaa IV | Lexington, MA | 27-Gur-2023 | 13-Bit-2023 | Mirkaneffame |
Baajanni gatii gadii gatii hojii iyyannoo tokkoo tokkoon irratti dhiyaate yoo ta'u, gara baajannaa waggaatti jijjiirame; lakkoofsa hojii guutuu hamma guyyaa guutuu qofa fayyadama. LCA mirkaneessa viizaa miti; LCA tokko hojii hedduu haguuchuuf ni danda'a. Madda: Dhaabbata Hojii Ameerikaa, OFLC LCA Disclosure Data, bara maallaqaa 2023–2026 (murtii haaraa 30-Wax-2026).